T Cell gets patent for TRAx:
This article was originally published in Clinica
T Cell Sciences has received a patent for its CD4+ lymphocyte enumeration immunoassay. The patent covers T Cell's technique for differentiating between cell bound and intracellular T cell antigens as well as total antigen quantitation. The TRAx kit, which is used for monitoring HIV progression was cleared by the FDA in May 1995 and is sold in the US by Diamedix, a division of Ivax.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.